<DOC>
	<DOC>NCT01460719</DOC>
	<brief_summary>An open-label, multicenter study to evaluate the safety and immunogenicity of inactivated Varicella-Zoster Virus (V212) vaccine in participants with hematologic malignancies (HM) who are currently receiving anti-CD20 monoclonal antibodies.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Diagnosed with a HM and is receiving treatment with antiCD20 monoclonal antibodies and is not likely to undergo hematopoietic cell transplant (HCT). Has a predicted life expectancy of â‰¥ 12 months. Has prior history of varicella or antibodies to VZV due to exposure to the disease in a country where the disease is common. All female participants of childbearing potential must have a negative serum or urine pregnancy test. A history of allergic reaction to any vaccine component (including gelatin) or an anaphylactic/anaphylactoid reaction to neomycin. Prior history of HZ within 1 year of enrollment. Prior receipt of any varicella or zoster vaccine. Participant is pregnant or breastfeeding or expecting to conceive within the period of 2 weeks prior to enrollment throughout 6 months after last vaccination dose. Any live virus vaccine administered or scheduled in the period from 4 weeks prior to Dose 1 through 28 days postvaccination dose 4. Any inactivated vaccine administered or scheduled within the period from 7 days prior to, through 7 days following, any dose of study vaccine. Participant is currently participating or has participated in a study with an investigational antiCD20 monoclonal antibody within 3 months of signing informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>